• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成纤维细胞生长因子受体在致癌作用中的作用。

Roles of fibroblast growth factor receptors in carcinogenesis.

机构信息

Department of Biochemistry, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway.

出版信息

Mol Cancer Res. 2010 Nov;8(11):1439-52. doi: 10.1158/1541-7786.MCR-10-0168. Epub 2010 Oct 13.

DOI:10.1158/1541-7786.MCR-10-0168
PMID:21047773
Abstract

The fibroblast growth factor receptors (FGFR) play essential roles both during development and in the adult. Upon ligand binding, FGFRs induce intracellular signaling networks that tightly regulate key biological processes, such as cell proliferation, survival, migration, and differentiation. Deregulation of FGFR signaling can thus alter tissue homeostasis and has been associated with several developmental syndromes as well as with many types of cancer. In human cancer, FGFRs have been found to be deregulated by multiple mechanisms, including aberrant expression, mutations, chromosomal rearrangements, and amplifications. In this review, we will give an overview of the main FGFR alterations described in human cancer to date and discuss their contribution to cancer progression.

摘要

成纤维细胞生长因子受体(FGFR)在发育和成年期都发挥着重要作用。配体结合后,FGFR 诱导细胞内信号网络,这些信号网络紧密调节关键的生物过程,如细胞增殖、存活、迁移和分化。因此,FGFR 信号的失调会改变组织的平衡,并与几种发育综合征以及许多类型的癌症有关。在人类癌症中,已经发现 FGFR 通过多种机制失调,包括异常表达、突变、染色体重排和扩增。在这篇综述中,我们将概述迄今为止在人类癌症中描述的主要 FGFR 改变,并讨论它们对癌症进展的贡献。

相似文献

1
Roles of fibroblast growth factor receptors in carcinogenesis.成纤维细胞生长因子受体在致癌作用中的作用。
Mol Cancer Res. 2010 Nov;8(11):1439-52. doi: 10.1158/1541-7786.MCR-10-0168. Epub 2010 Oct 13.
2
Fibroblast growth factors and their receptors in cancer.成纤维细胞生长因子及其受体在癌症中的作用。
Biochem J. 2011 Jul 15;437(2):199-213. doi: 10.1042/BJ20101603.
3
Cellular signaling by fibroblast growth factor receptors.成纤维细胞生长因子受体介导的细胞信号传导
Cytokine Growth Factor Rev. 2005 Apr;16(2):139-49. doi: 10.1016/j.cytogfr.2005.01.001. Epub 2005 Feb 1.
4
Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.靶向成纤维细胞生长因子受体可阻断 PI3K/AKT 信号通路,诱导细胞凋亡,并抑制乳腺肿瘤生长和转移。
Cancer Res. 2010 May 15;70(10):4151-62. doi: 10.1158/0008-5472.CAN-09-4479. Epub 2010 May 11.
5
De-regulated FGF receptors as therapeutic targets in cancer.异常激活的 FGF 受体作为癌症治疗靶点。
Pharmacol Ther. 2010 Jan;125(1):105-17. doi: 10.1016/j.pharmthera.2009.10.001. Epub 2009 Oct 27.
6
Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases.受体酪氨酸激酶致癌激活过程中内吞作用的破坏。
Am J Physiol Endocrinol Metab. 2009 May;296(5):E973-84. doi: 10.1152/ajpendo.90857.2008. Epub 2009 Feb 24.
7
Fibroblast growth factor signaling in Caenorhabditis elegans.秀丽隐杆线虫中的成纤维细胞生长因子信号传导
Bioessays. 2001 Dec;23(12):1120-30. doi: 10.1002/bies.10007.
8
Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.膀胱及其他癌症中异常的成纤维细胞生长因子受体信号传导
Differentiation. 2007 Nov;75(9):831-42. doi: 10.1111/j.1432-0436.2007.00210.x. Epub 2007 Aug 14.
9
Small molecule inhibition of fibroblast growth factor receptors in cancer.小分子抑制癌症中的成纤维细胞生长因子受体。
Cytokine Growth Factor Rev. 2013 Oct;24(5):467-75. doi: 10.1016/j.cytogfr.2013.05.002. Epub 2013 Jul 2.
10
FGFR signalling in women's cancers.成纤维细胞生长因子受体信号在女性癌症中的作用。
Int J Biochem Cell Biol. 2013 Dec;45(12):2832-42. doi: 10.1016/j.biocel.2013.09.017. Epub 2013 Oct 19.

引用本文的文献

1
Structure-based identification of potent fibroblast growth factor receptor 4 (FGFR4) inhibitors as potential therapeutics for hepatocellular carcinoma.基于结构的强效成纤维细胞生长因子受体4(FGFR4)抑制剂的鉴定作为肝细胞癌的潜在治疗方法。
PeerJ. 2025 Jun 18;13:e19183. doi: 10.7717/peerj.19183. eCollection 2025.
2
FGFR inhibition as a new therapeutic strategy to sensitize glioblastoma stem cells to tumor treating fields.成纤维细胞生长因子受体(FGFR)抑制作为一种使胶质母细胞瘤干细胞对肿瘤治疗电场敏感的新治疗策略。
Cell Death Discov. 2025 Jun 4;11(1):265. doi: 10.1038/s41420-025-02542-5.
3
FGFR3 amplification is predictive of poor prognosis in esophageal squamous cell carcinoma patients.
FGFR3基因扩增可预测食管鳞状细胞癌患者的不良预后。
Virchows Arch. 2025 May 26. doi: 10.1007/s00428-024-03884-8.
4
Recent Developments in the Synthesis of Benzothiazoles and their Anti-cancer Mechanistic Discoveries.苯并噻唑的合成及其抗癌机制发现的最新进展
Curr Pharm Des. 2025;31(32):2559-2593. doi: 10.2174/0113816128355783250212043621.
5
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World Setting.真实世界中晚期实体瘤患者致癌性成纤维细胞生长因子受体改变的预后影响
Cancer Med. 2025 Feb;14(4):e70546. doi: 10.1002/cam4.70546.
6
Digestive cancers: mechanisms, therapeutics and management.消化系统癌症:机制、治疗方法与管理
Signal Transduct Target Ther. 2025 Jan 15;10(1):24. doi: 10.1038/s41392-024-02097-4.
7
SNRPE, an Oncofetal Protein: can be a Diagnostic Marker and Therapeutic Target for Oral Cancers?SNRPE,一种癌胚蛋白:能否成为口腔癌的诊断标志物和治疗靶点?
Head Neck Pathol. 2024 Oct 15;18(1):99. doi: 10.1007/s12105-024-01709-3.
8
FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies.膀胱癌中 FGFR3 的改变:靶向治疗的敏感性和耐药性。
Cancer Commun (Lond). 2024 Oct;44(10):1189-1208. doi: 10.1002/cac2.12602. Epub 2024 Aug 19.
9
Phase 3 THOR Japanese subgroup analysis: erdafitinib in advanced or metastatic urothelial cancer and fibroblast growth factor receptor alterations.三期 THOR 日本亚组分析:erdafitinib 治疗晚期或转移性尿路上皮癌和成纤维细胞生长因子受体改变。
Int J Clin Oncol. 2024 Oct;29(10):1516-1527. doi: 10.1007/s10147-024-02583-3. Epub 2024 Jul 17.
10
Adverse events in patients with advanced urothelial carcinoma treated with erdafitinib: a retrospective pharmacovigilance study.使用厄达替尼治疗的晚期尿路上皮癌患者的不良事件:一项回顾性药物警戒研究。
Front Pharmacol. 2023 Nov 21;14:1266890. doi: 10.3389/fphar.2023.1266890. eCollection 2023.